These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). Montironi R; Scattoni V; Mazzucchelli R; Lopez-Beltran A; Bostwick DG; Montorsi F Eur Urol; 2006 Oct; 50(4):666-74. PubMed ID: 16930809 [TBL] [Abstract][Full Text] [Related]
5. Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma. Rapp DE; Msezane LP; Reynolds WS; Lotan TL; Obara P; O'Connor RC; Taxy JB; Gerber GS; Zagaja GP Can J Urol; 2009 Feb; 16(1):4484-9. PubMed ID: 19222887 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer early detection clinical practice guidelines in oncology. Babaian RJ; Partin AW; J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536 [TBL] [Abstract][Full Text] [Related]
8. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. Merrimen JL; Jones G; Walker D; Leung CS; Kapusta LR; Srigley JR J Urol; 2009 Aug; 182(2):485-90; discussion 490. PubMed ID: 19524976 [TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen best practice statement: 2009 update. Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717 [TBL] [Abstract][Full Text] [Related]
10. A framework for the identification of men at increased risk for prostate cancer. Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625 [TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer]. Hinotsu S Gan To Kagaku Ryoho; 2010 Apr; 37(4):620-3. PubMed ID: 20414018 [TBL] [Abstract][Full Text] [Related]
13. Draft screening guidelines spark debate: possible drawbacks and long-term effects of new draft guidelines for prostate cancer screening. Printz C Cancer; 2012 May; 118(9):2335-6. PubMed ID: 22522608 [No Abstract] [Full Text] [Related]
14. Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia. Godoy G; Taneja SS Prostate Cancer Prostatic Dis; 2008; 11(1):20-31. PubMed ID: 17909565 [TBL] [Abstract][Full Text] [Related]
15. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. Capodice JL; Gorroochurn P; Cammack AS; Eric G; McKiernan JM; Benson MC; Stone BA; Katz AE J Soc Integr Oncol; 2009; 7(2):43-51. PubMed ID: 19476738 [TBL] [Abstract][Full Text] [Related]
17. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer]. Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556 [TBL] [Abstract][Full Text] [Related]
19. Risk factors, prevention and early detection of prostate cancer. Loeb S; Schaeffer EM Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157 [TBL] [Abstract][Full Text] [Related]
20. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. Schröder FH; Roobol MJ BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150 [No Abstract] [Full Text] [Related] [Next] [New Search]